REVIEW ARTICLE
Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation
Allan L. Klein, MD, FACCa,
R. Daniel Murray, PhDa and
Richard A. Grimm, DO, FACCa
a Cardiovascular Imaging Section, Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
Manuscript received April 19, 1999;
revised manuscript received October 6, 2000,
accepted November 10, 2000.
Reprint requests and correspondence: Dr. Allan L. Klein, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Department of Cardiology/Desk F-15, Cleveland, Ohio 44195 kleina{at}ccf.org
Electrical cardioversion of patients with atrial fibrillation (AF) is frequently performed to relieve symptoms and improve cardiac performance. Patients undergoing cardioversion are treated conventionally with therapeutic anticoagulation for three weeks before and four weeks after cardioversion to decrease the risk of thromboembolism. A transesophageal echocardiography (TEE)-guided strategy has been proposed as an alternative that may lower stroke and bleeding events. Patients without atrial cavity thrombus or atrial appendage thrombus by TEE are cardioverted on achievement of therapeutic anticoagulation, whereas cardioversion is delayed in higher risk patients with thrombus. The aim of this review is to discuss the issues and controversies associated with the management of patients with AF undergoing cardioversion. We provide an overview of the TEE-guided and conventional anticoagulation strategies in light of the recently completed Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) clinical trial. The two management strategies comparably lower the patients embolic risk when the guidelines are properly followed. The TEE-guided strategy with shorter term anticoagulation may lower the incidence of bleeding complications and safely expedite early cardioversion. The inherent advantages and disadvantages of both strategies are presented. The TEE-guided approach with short-term anticoagulation is considered to be a safe and clinically effective alternative to the conventional approach, and it is advocated in patients in whom earlier cardioversion would be clinically beneficial.
|
Abbreviations and Acronyms
| | ACC | = American College of Cardiology | | AHA | = American Heart Association | | ACCP | = American College of Chest Physicians | | ACUTE | = Assessment of Cardioversion Using Transesophageal Echocardiography trial | | AF | = atrial fibrillation | | DC | = direct current | | INR | = international normalized ratio | | TEE | = transesophageal echocardiography | | TTE | = transthoracic echocardiography |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Garcia
Detection of left atrial appendage thrombus by cardiac computed tomography: a word of caution.
J. Am. Coll. Cardiol. Img.,
January 1, 2009;
2(1):
77 - 79.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. F Tops, E. E van der Wall, M. J Schalij, and J. J Bax
Multi-modality imaging to assess left atrial size, anatomy and function
Heart,
November 1, 2007;
93(11):
1461 - 1470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Gupta, M. J Earley, G. A Haywood, L. Richmond, M. Fitzgerald, P. Kojodjojo, S. C Sporton, N. S Peters, P. Broadhurst, R. J Schilling, et al.
Can atrial fibrillation with a coarse electrocardiographic appearance be treated with catheter ablation of the tricuspid valve-inferior vena cava isthmus? Results of a multicentre randomised controlled trial
Heart,
June 1, 2007;
93(6):
688 - 693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Marchiondo
Transesophageal Imaging and Interventions: Nursing Implications
Crit. Care Nurse,
April 1, 2007;
27(2):
25 - 35.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Klein, S. E. Jasper, W. E. Katz, J. F. Malouf, L. A. Pape, M. F. Stoddard, C. Apperson-Hansen, E. A. Lieber, and The ACUTE II Steering and Publications Committee F
The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: Assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study
Eur. Heart J.,
December 1, 2006;
27(23):
2858 - 2865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. M. Wazni, H.-M. Tsao, S.-A. Chen, H.-H. Chuang, W. Saliba, A. Natale, and A. L. Klein
Cardiovascular Imaging in the Management of Atrial Fibrillation
J. Am. Coll. Cardiol.,
November 21, 2006;
48(10):
2077 - 2084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Strandberg, M.J. P. Raatikainen, M. Niemela, M. Luotolahti, J. Hartiala, and K.E. J. Airaksinen
Clinical practicality and predictive value of transoesophageal echocardiography in early cardioversion of atrial fibrillation
Europace,
June 1, 2006;
8(6):
408 - 412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Achenbach, D Sacher, D Ropers, K Pohle, U Nixdorff, U Hoffmann, G Muschiol, F A Flachskampf, and W G Daniel
Electron beam computed tomography for the detection of left atrial thrombi in patients with atrial fibrillation
Heart,
December 1, 2004;
90(12):
1477 - 1478.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Klein, R. D. Murray, E. R. Becker, S. D. Culler, W. S. Weintraub, S. E. Jasper, E. A. Lieber, C. Apperson-Hansen, A. M. Heerey, R. A. Grimm, et al.
Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: The ACUTE economic data at eight weeks
J. Am. Coll. Cardiol.,
April 7, 2004;
43(7):
1217 - 1224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. McNamara, L. J. Tamariz, J. B. Segal, and E. B. Bass
Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography
Ann Intern Med,
December 16, 2003;
139(12):
1018 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W Troughton, C. R Asher, and A. L Klein
The role of echocardiography in atrial fibrillation and cardioversion
Heart,
December 1, 2003;
89(12):
1447 - 1454.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Palinkas, E. Antonielli, E. Picano, A. Pizzuti, A. Varga, B. Nyuzo, J.M. Alegret, A. Bonzano, M. Tanga, A. Coppolino, et al.
Clinical value of left atrial appendage flow velocity for predicting of cardioversion success in patients with non-valvular atrial fibrillation
Eur. Heart J.,
December 1, 2001;
22(23):
2201 - 2208.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T Bartel and R Erbel
Transoesophageal echocardiography for immediate and safe cardioversion in patients with atrial fibrillation
Eur. Heart J.,
November 2, 2001;
22(22):
2041 - 2044.
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Anderson, P.J. Devereaux, S. Yusuf, G. Barbaro, M. Soldini, G. Giancaspro, J. R. Stratton, A. L. Klein, R. D. Murray, and R. A. Grimm
Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
N. Engl. J. Med.,
September 13, 2001;
345(11):
837 - 839.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Sparks and J. M. Kalman
Is atrial flutter a risk factor for stroke?
J. Am. Coll. Cardiol.,
September 1, 2001;
38(3):
785 - 788.
[Full Text]
[PDF]
|
 |
|
|